Verus Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Verus Capital Partners's LLY Position: Q1 2026 in Review
Verus Capital Partners reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $153K and leaving 956 shares worth $879K. The position accounts for 0.06% of the portfolio, ranked #184.
Verus Capital Partners first reported a position in LLY in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.4M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Verus Capital Partners held 956 shares of Eli Lilly worth $879K as of Q1 2026.
- Verus Capital Partners sold 151 Eli Lilly shares in Q1 2026, an estimated $153K.
- Eli Lilly made up 0.06% of Verus Capital Partners's portfolio in Q1 2026, its #184 holding.
- Verus Capital Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 19 quarters since.
- Verus Capital Partners's Eli Lilly position peaked at $1.4M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.